Tumorigenesis due to dysfunction of PP6, a novel target for cancer treatment.
Project/Area Number |
17K07187
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Tumor biology
|
Research Institution | Miyagi Prefectural Hospital Organization Miyagi Cancer Center |
Principal Investigator |
Shima Hiroshi 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん薬物療法研究部, 部長 (10196462)
|
Co-Investigator(Kenkyū-buntansha) |
佐藤 郁郎 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), ティッシュバンクセンター, 部長 (50225918)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2019: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | プロテインホスファターゼ / Kras / セリン・スレオニンプロテインホスファターゼ6型 / イニシエーション / プロモーション / 皮膚がん / PP6 / メラノーマ / 発がん |
Outline of Final Research Achievements |
Here, we address the function of protein phosphatase 6 (PP6) loss on K-ras-initiated tumorigenesis in keratinocytes. To do so, we developed tamoxifen-inducible double mutant (K-rasG12D-expressing and Ppp6c-deficient) mice in which K-rasG12D expression is driven by the cytokeratin 14 (K14) promoter. Doubly-mutant mice showed early onset tumor formation in lip, nipples, external genitalia, anus and palms, and had to be sacrificed by three weeks after induction by tamoxifen, while comparably-treated K-rasG12D-expressing mice did not. HE-staining of lip tumors before euthanasia revealed that all were papillomas, some containing focal squamous cell carcinoma. Immunohistochemical analysis of lip tumor suggested that protein synthesis and survival signals are enhanced in lip tissues of doubly-mutant mice. We also developed melanocyte specific tamoxifen-inducible double mutant (BRAFV600E-expressing and Ppp6c-deficient) mic mice to address the function of PP6 in melanogenesis. (984)
|
Academic Significance and Societal Importance of the Research Achievements |
プロテインキナーゼの異常が発がんの原因となっていることは明らかである。一方で、ホスファターゼが原因となる発がんに関しては研究が遅れていた。申請者は、PP6ホスファターゼ (Ppp6c)遺伝子を 皮膚特異的に欠損するマウスを作製し、DMBA処理や紫外線照射により腫瘍が高率に発生する事を見いだした。本研究は、これまでの研究の継続として、Ppp6cと発がんとの関連を明らかにすることである。(193)
|
Report
(4 results)
Research Products
(23 results)
-
-
-
-
[Journal Article] PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.2018
Author(s)
M Morita, T Sato, M Nomura, Y Sakamoto, Y Inoue, R Tanaka, S Ito, K Kurosawa, K Yamaguchi, Y Sugiura, H Takizaki, Y Yamashita, R Katakura, I Sato, Y Okada, H Watanabe, G Kondoh, et al.
-
Journal Title
Cancer Cell
Volume: 12
Issue: 3
Pages: 355-367
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Loss of protein phosphatase 6 in mouse keratinocytes enhances K-rasG12D-driven tumor promotion.2018
Author(s)
Kurosawa K, Inoue Y, Kakugawa Y, Yamashita Y, Kanazawa K, Kishimoto K, Nomura M, Momoi Y, Sato I, Chiba N, Suzuki M, Ogoh H, Yamada H, Miura K, Watanabe T, Tanuma N, Tachi M, and Shima H
-
Journal Title
Cancer Science
Volume: 印刷中
Related Report
Peer Reviewed
-
[Journal Article] Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells.2017
Author(s)
Sato T, Morita M, Tanaka R, Inoue Y, Nomura M, Sakamoto Y, Miura K, Ito S, Sato I, Tanaka N, Abe J, Takahashi S, Kawai M, Sato M, Hippo Y, Shima H, Okada Y, Tanuma N
-
Journal Title
Oncol Lett.
Volume: 14(6)
Pages: 6863-6868
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.2017
Author(s)
Yoshimaru T, Ono M, Bando Y, Chen YA, Mizuguchi K, Shima H, Komatsu M, Imoto I, Izumi K, Honda J, Miyoshi Y, Sasa M, Katagiri T
-
Journal Title
Nature Communications
Volume: 印刷中
Issue: 1
Pages: 15427-15427
DOI
NAID
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Drug delivery of oral anti-cancer fluoropyrimidine agents.2017
Author(s)
Miura K, Shima H, Takebe N, Julie R, Satoh K, Kakugawa Y, Satoh M, Kinouchi M, Yamamoto K, Hasegawa Y, Kawai M, Kanazawa K, Fujiya T, Unno M and Katakura R.
-
Journal Title
Expert Opin.Drug Deliv
Volume: 印刷中
Issue: 12
Pages: 1-12
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Enhanced expression of PKM2 is involved in the gastric cancer development via regulating cancer specific metabolism.2017
Author(s)
Shiroki T, Yokoyama M, Tanuma N, Maejima R, Tamai K, Yamaguchi K, Oikawa T, Noguchi T, Miura K, Fujiya T, Shima H, Sato I, Kamiya N, Hatakeyama M, Iijima K, Shimosegawa T and Satoh K.
-
Journal Title
Cancer Science
Volume: 印刷中
Issue: 5
Pages: 931-940
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-